News – Page 1020 – Endpoints News

Roche's Sophie Kornowski joins Chris Viehbacher at Gurnet Point; FDA will give Roche's groundbreaking flu drug speedy ...

7 years ago

CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar

7 years ago

Achaogen hits, then misses: FDA OKs Zemdri for cUTIs, but rejects second indication

7 years ago

Brainstorm backs off a controversial plan to sell its experimental ALS med, but this issue is far from over

7 years ago

A monster discovery deal between AbbVie and Google’s Calico gets a new lease on the lab, with $1B more to back ...

7 years ago

Bill Haney believes there’s a better way to build a biotech — and now he has $100M more at Skyhawk to prove it

7 years ago

FDA to release list of surrogate endpoints in oncology

7 years ago

FDA OKs first cannabinoid, gives green light to GW Pharma’s Epidiolex for rare seizures

7 years ago

Dementia Discovery Fund closes $350M, recruits Celgene exec as CEO; Ex-Lazard banker Ian Woo joins C-Bridge and ...

7 years ago

Food-sourced microbiome drugs get $101M megaround for Flagship's Kaleido

7 years ago

Oops. Pfizer's CDK 4/6 blockbuster Ibrance flunks the OS mark for breast cancer

7 years ago

Sudden death forces Sophiris to halt followup therapy in prostate cancer study — shares crushed

7 years ago

Pancreatic cancer study failure cripples a Merrimack drug, forcing a coup de grâce and pipeline retreat

7 years ago

Akero elbows its way into a crowded NASH field, with $65M and a strategy for tackling a blockbuster market

7 years ago

After Rova-T bust, AbbVie plans new solid tumor assault, licensing next-gen CAR-T tech from Calibr

7 years ago

What you need to know about this record-setting biotech IPO burst as 5 more crash the party looking for $547M

7 years ago

Roche’s Tecentriq scoops up a big win in small cell lung cancer, grabbing the lead in frontline cases

7 years ago

UK startup NodThera banks a $40M round with plans to conquer a closely-studied inflammatory target

7 years ago

A slimmer FDA: White House proposes 30% cut to headcount under reorganization

7 years ago

Nanobiotix shares rocket up on a marginal success for soft tissue sarcoma; AstraZeneca wins pioneering PD-L1 OK in ...

7 years ago

Bristol-Myers clears another hurdle in Merck lung cancer showdown — but big challenges remain

7 years ago

Boehringer backs €20B R&D game plan with a $272M blueprint for new facility — 100 new hires

7 years ago

J&J opens up a new biotech incubator, polishing the Big Apple's ambitions to create a major hub

7 years ago

In high-level reshuffle, Roche gives James Sabry the global reins on deal-making — overseeing pRED and gRED

7 years ago

First page Previous page 1017 1018 101910201021 1022 1023 Next page Last page